Search

54 results for “Patient safety”

• CommentaryOpen Access

  The new factor Xa inhibitor: Apixaban

  Sangeeta Bhanwra, Kaza Ahluwalia

  Vol. 5 · Issue 1 · pp. 12–14

  https://doi.org/10.4103/0976-500X.124409
  Full text ↗PDF

• Molecules of the MillenniumOpen Access

  Macitentan: An important addition to the treatment of pulmonary arterial hypertension

  Anjan Khadka, Dick B Singh Brashier, Anantharamu Tejus, Ashok Kumar Sharma

  Vol. 6 · Issue 1 · pp. 53–57

  https://doi.org/10.4103/0976-500X.149151
  Full text ↗PDF

• Case ReviewOpen Access

  Nexavar®-related adverse reactions: Calabrian (Italy) experience for sorafenib exposition in 2012

  Felisa Cilurzo, Orietta Staltari, Marinella Patanè, Michele Ammendola, Caterina Garaffo, Eugenio Donato Paola

  Vol. 4 · Issue 1 · pp. S86–S86

  https://doi.org/10.4103/0976-500X.120971
  Full text ↗PDF

• Review ArticleOpen Access

  Riociguat: Something new in pulmonary hypertension therapeutics?

  Elangovan Shanmugam, Amrita Jena, Melvin George

  Vol. 6 · Issue 1 · pp. 3–6

  https://doi.org/10.4103/0976-500X.149132
  Full text ↗PDF

• Review ArticleOpen Access

  A Systematic Review and Meta-analysis of Selective Cyclooxygenase-2 Inhibitors and Non-selective Non-steroidal Anti-inflammatory Drugs for Acute Gout

  Swathy Govindaswamy, Kavya Ponnusamy, Indhumathi S., Vineeth Anil, Jayalakshmi Venugopal, Dhivya P. Sundaram

  Vol. 15 · Issue 2 · pp. 122–132

  https://doi.org/10.1177/0976500X241240629
  Full text ↗PDF

• EditorialOpen Access

  The national essential medicines list of India: Time to revise and purge the mistakes

  Gitanjali B

  Vol. 1 · Issue 2 · pp. 73–74

  https://doi.org/10.4103/0976-500X.72346
  Full text ↗PDF

• Case ReportOpen Access

  Adrenal suppression following herbal remedy for rheumatoid arthritis

  Balasekar Premkumar, Muppavarapu Srinivasa Murthy, Karuppasamy Rajagopal, Vadivelmurugan Nagasubramani Nagaprabu, Sree Madhuri Ponugupati

  Vol. 6 · Issue 2 · pp. 110–113

  https://doi.org/10.4103/0976-500X.155493
  Full text ↗PDF

• Review ArticleOpen Access

  Ustekinumab: In Psoriasis and Beyond—A Dermatological Perspective

  Aditya Kumar Bubna, Vinayak Viplav

  Vol. 15 · Issue 2 · pp. 105–121

  https://doi.org/10.1177/0976500X241240643
  Full text ↗PDF

• Review ArticleOpen Access

  Exploring the Novel Therapeutic Potential of N-acetylcysteine in Depression, Bipolar Disorders and Anxiety

  Reuben P. Syiem, Julie B. Wahlang, Krishnamoorthi R., Pavan B. Kalyan, Diana Nahakpam, Arky Jane Langstieh

  Vol. 15 · Issue 2 · pp. 133–141

  https://doi.org/10.1177/0976500X241246402
  Full text ↗PDF

• ReportOpen Access

  Annual report on adverse events related with vaccines use in Calabria (Italy): 2012

  Orietta Staltari, Felisa Cilurzo, Benedetto Caroleo, Alexia Greco, Francesco Corasaniti, Maria Antonietta Genovesi, Luca Gallelli

  Vol. 4 · Issue Supplement 1 · pp. S61–S62

  https://doi.org/10.4103/0976-500X.120951
  Full text ↗PDF

• Research ArticleOpen Access

  Adverse Drug Reactions to Antifungals Used in the Management of COVID-19 Associated Rhino-Orbito-Cerebral Mucormycosis

  Smrati Tiwari, Zahaan Vakil

  Vol. 13 · Issue 2 · pp. 197–202

  https://doi.org/10.1177/0976500X221105759
  Full text ↗PDF

• CorrespondenceOpen Access

  An adverse drug reaction clinic: Breathing fresh life into the pharmacovigilance programme

  Dick B. S. Brashier, Sushil Sharma

  Vol. 3 · Issue 1 · pp. 74–75

  https://doi.org/10.4103/0976-500X.92501
  Full text ↗PDF

• Research LetterOpen Access

  Parents’ awareness and perspective on off‑label medicines use in children

  Mohd Masnoon Saiyed, Aarohi Prajapati, Gaurang Shah

  Vol. 6 · Issue 2 · pp. 88–89

  Full text ↗PDF

• Review ArticleOpen Access

  Epilepsy: Novel therapeutic targets

  Ashish P. Anovadiya, Jayesh J. Sanmukhani, C. B. Tripathi

  Vol. 3 · Issue 2 · pp. 112–117

  https://doi.org/10.4103/0976-500X.95505
  Full text ↗PDF